DexCom, Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$6.34B
↓-2.2% -$145Mvs FY2024
Total Liabilities
$3.59B
↓-18.0% -$788Mvs FY2024
Equity
$2.75B
↑+30.6% +$643Mvs FY2024
Cash
$918M
↑+51.4% +$312Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $6.34B | $6.48B |
| Current Assets | $4.03B | $4.30B |
| Cash | $918M | $606M |
| ST Investments | $0 | $0 |
| Receivables | $1.22B | $1.01B |
| Inventory | $629M | $543M |
| Other Current | $1.27B | $2.15B |
| Non-Current Assets | $2.31B | $2.18B |
| PPE | $0 | $0 |
| Goodwill | $24M | $23M |
| Intangibles | $71M | $103M |
| Investments | $218M | $119M |
| Other Non-Current | $1.99B | $1.94B |
| Total Liab+Eq | $6.34B | $6.48B |
| Current Liab. | $2.14B | $2.93B |
| Accounts Payable | $0 | $0 |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $8M |
| Other CL | $2.14B | $2.92B |
| Non-Current Liab. | $1.45B | $1.45B |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $1.45B | $1.45B |
| Equity | $2.75B | $2.10B |
| Retained Earnings | $2.43B | $1.60B |
| Other Equity | $312M | $505M |
QuarterCharts · SEC EDGAR data · DXCM · Comparing FY2025 vs FY2024